Enzo Biochem, Inc.
ENZ
$1.09
-$0.02-1.80%
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.06M | -6.62M | 57.43M | -15.19M | -11.32M |
| Total Depreciation and Amortization | 267.00K | 270.00K | 606.00K | 648.00K | 626.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -387.00K | 2.48M | -79.70M | 565.00K | -777.00K |
| Change in Net Operating Assets | -5.76M | -9.51M | 4.64M | 8.92M | 5.27M |
| Cash from Operations | -8.94M | -13.37M | -17.03M | -5.05M | -6.20M |
| Capital Expenditure | -25.00K | -254.00K | -573.00K | -666.00K | -869.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -25.00K | -254.00K | 101.17M | -666.00K | -869.00K |
| Total Debt Issued | -- | -- | 16.28M | 7.57M | -- |
| Total Debt Repaid | -22.00K | -51.00K | -20.52M | -4.31M | -62.00K |
| Issuance of Common Stock | -- | -- | 386.00K | 14.00K | -- |
| Repurchase of Common Stock | 0.00 | -467.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.00K | -518.00K | -4.24M | 3.27M | -62.00K |
| Foreign Exchange rate Adjustments | 19.00K | -20.00K | -155.00K | 26.00K | 48.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.97M | -14.17M | 79.74M | -2.42M | -7.08M |
